BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 14585155)

  • 1. Advances in the diagnosis and treatment of leprosy.
    Katoch VM
    Expert Rev Mol Med; 2002 Jul; 4(15):1-14. PubMed ID: 14585155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse with multibacillary leprosy caused by rifampicin sensitive organisms following paucibacillary multidrug therapy.
    Soares DJ; Neupane K; Britton WJ
    Lepr Rev; 1995 Sep; 66(3):210-3. PubMed ID: 7500815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the epidemiology, diagnosis, and treatment of leprosy.
    Reibel F; Cambau E; Aubry A
    Med Mal Infect; 2015 Sep; 45(9):383-93. PubMed ID: 26428602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of gene probes and gene amplification techniques for diagnosis and monitoring of treatment in childhood leprosy.
    Kamal R; Dayal R; Katoch VM; Katoch K
    Lepr Rev; 2006 Jun; 77(2):141-6. PubMed ID: 16895070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leprosy. An update: definition, pathogenesis, classification, diagnosis, and treatment.
    Eichelmann K; González González SE; Salas-Alanis JC; Ocampo-Candiani J
    Actas Dermosifiliogr; 2013 Sep; 104(7):554-63. PubMed ID: 23870850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
    Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
    Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and interactions of antileprosy drugs.
    George J
    Biochem Pharmacol; 2020 Jul; 177():113993. PubMed ID: 32339493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy.
    Joseph P; Ponnaiya J; Das M; Chaitanya VS; Arumugam S; Ebenezer M
    Indian J Lepr; 2016; 88(3):147-58. PubMed ID: 30207440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
    Guerrero MI; Colorado CL; Torres JF; León CI
    Biomedica; 2014 Apr; 34 Suppl 1():137-47. PubMed ID: 24968045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
    Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A colorimetric PCR method for the detection of M. leprae in skin biopsies from leprosy patients.
    Jamil S; Wilson SM; Hacket M; Hussain R; Stoker NG
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):512-20. PubMed ID: 7868947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of drugs for activity against Mycobacterium leprae.
    Baohong J; Matsuo Y; Colston MJ
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):836-42. PubMed ID: 3325576
    [No Abstract]   [Full Text] [Related]  

  • 13. Develop and Field Evolution of Single Tube Nested PCR, SYBRGreen PCR Methods, for the Diagnosis of Leprosy in Paraffin-embedded Formalin Fixed Tissues in Yunnan Province, a Hyper endemic Area of Leprosy in China.
    Chen X; Xing Y; He J; Tan F; You Y; Wen Y
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007731. PubMed ID: 31577795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending The Leprosy Mission (TLM) Hospitals in India.
    Lavania M; Jadhav RS; Chaitanya VS; Turankar R; Selvasekhar A; Das L; Darlong F; Hambroom UK; Kumar S; Sengupta U
    Lepr Rev; 2014 Sep; 85(3):177-85. PubMed ID: 25509718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
    Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
    Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acedapsone (DADDS) treatment of leprosy patients in the Karimui of Papua New Guinea: status at six years.
    Russell DA; Shepard CC; McRae DH; Scott GC; Vincin DR
    Am J Trop Med Hyg; 1975 May; 24(3):485-95. PubMed ID: 1098496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of leprosy: epidemiology, basic science and clinical perspectives.
    Suzuki K; Akama T; Kawashima A; Yoshihara A; Yotsu RR; Ishii N
    J Dermatol; 2012 Feb; 39(2):121-9. PubMed ID: 21973237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of Mycobacterium leprae in the peripheral nerve as compared to the skin of multidrug-treated leprosy patients.
    Shetty VP; Suchitra K; Uplekar MW; Antia NH
    Lepr Rev; 1992 Dec; 63(4):329-36. PubMed ID: 1479872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multibacillary leprosy with an incubation period exceeding 50 years.
    Taggart M; Kelly A; Stell R; Chu E
    BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35790324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hansen's disease: case report and review of literature].
    Concha R M; Cossio T ML; Salazar S I; Fich S F; Pérez C C; González B S
    Rev Chilena Infectol; 2008 Feb; 25(1):64-9. PubMed ID: 18273528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.